Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | ACP3 | P15309 | 2/20 | 0.43 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | MGLL | Q99685 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | MMP3 | P08254 | 1/20 | 0.40 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.40 |
| ▸ | MMP8 | P22894 | 1/20 | 0.39 |
| ▸ | MMP14 | P50281 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14245147 | 0.85 | ACP3 (0.47) | CYP1A2ALDH1A1ACP3PTPN5CA2 | |
| Benzene SCHEMBL28274900 | 0.84 | CA2 (0.52) | ALDH1A1CA2TDP1CA4CA5A | |
| SCHEMBL140712 | 0.84 | CA2 (0.52) | ALDH1A1CA2TDP1CA4CA5A | |
| SCHEMBL28809780 | 0.84 | CA2 (0.52) | ALDH1A1CA2TDP1CA4CA5A | |
| SCHEMBL17711516 | 0.83 | ACP3 (0.52) | CYP1A2ALDH1A1ACP3PTPN5CA2 | |
| SCHEMBL27433007 | 0.81 | CA2 (0.50) | ALDH1A1CA2TDP1CA4CA5A | |
| SCHEMBL11145592 | 0.81 | ALDH1A1 (0.53) | CYP1A2ALDH1A1ACP3PTPN5CA2 | |
| SCHEMBL14339266 | 0.81 | ALDH1A1 (0.53) | CYP1A2ALDH1A1ACP3PTPN5CA2 | |
| SCHEMBL14339275 | 0.81 | ALDH1A1 (0.53) | CYP1A2ALDH1A1ACP3PTPN5CA2 | |
| Biphenyl SCHEMBL122229 | 0.81 | ALDH1A1 (0.60) | CYP1A2ALDH1A1ACP3PTPN5CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115926175-A | Halogen-free polyphosphate flame retardant with high polymerization degree and preparation method thereof | 缔久高科技材料(南通)有限公司 | 2023-04-07 | — | — | CN | disclosed |
| EP-3541890-B1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2020-10-28 | — | — | EP | disclosed |
| US-20190352318-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2019-11-21 | — | — | US | disclosed |
| WO-2018091435-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2018-05-24 | — | — | WO | disclosed |
| US-8865321-B2 | Organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2014-10-21 | — | — | US | disclosed |
| US-8865321-B2 | Organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2014-10-21 | — | — | US | disclosed |
| EP-1669398-B1 | FLAME-RETARDANT PROCESSED RESIN OBTAINED WITH A REACTIVE FLAME RETARDANT | FUJI ELECTRIC CO LTD (JP) | 2014-01-08 | — | — | EP | disclosed |
| EP-2344607-B1 | ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2013-04-10 | — | — | EP | disclosed |
| US-8142864-B2 | Cellulose ester pellets, cellulose ester film, manufacturing method of cellulose ester film, polarizing plate, and liquid crystal display | KONICA MINOLTA OPTO, INC. (JP) | 2012-03-27 | — | — | US | disclosed |
| US-8142864-B2 | Cellulose ester pellets, cellulose ester film, manufacturing method of cellulose ester film, polarizing plate, and liquid crystal display | KONICA MINOLTA OPTO, INC. (JP) | 2012-03-27 | — | — | US | disclosed |
| US-20100047480-A1 | CELLULOSE ESTER PELLETS, CELLULOSE ESTER FILM, MANUFACTURING METHOD OF CELLULOSE ESTER FILM, POLARIZING PLATE, AND LIQUID CRYSTAL DISPLAY | C/O KONICA MINOLTA OPTO, INC. (JP) | 2010-02-25 | — | — | US | disclosed |
| US-7557152-B2 | Reactive flame retardant and flame-retardant resin processed article | FUJI ELECTRIC HOLDINGS CO., LTD. (JP) | 2009-07-07 | — | — | US | disclosed |
| US-20090043032-A1 | REACTIVE FLAME RETARDANT AND FLAME-RETARDANT RESIN PROCESSED ARTICLE | FUJI ELECTRIC HOLDINGS CO., LTD. (JP) | 2009-02-12 | — | — | US | disclosed |
| EP-1852489-A1 | REACTIVE FLAME RETARDANT AND FLAME-RETARDANT RESIN PROCESSED ARTICLE | FUJI ELECTRIC HOLDINGS CO., LTD.; (JP) | 2007-11-07 | — | — | EP | disclosed |
| EP-1669398-A1 | REACTIVE FLAME RETARDANT AND FLAME-RETARDANT PROCESSED RESIN OBTAINED WITH THE SAME | FUJI ELECTRIC HOLDINGS CO., LTD. (JP) | 2006-06-14 | — | — | EP | disclosed |
| EP-1303527-B1 | MATRIX METALLOPROTEINASE INHIBITORS | LEO PHARMA AS (DK) | 2004-09-29 | — | — | EP | disclosed |
| EP-1303527-A1 | MATRIX METALLOPROTEINASE INHIBITORS | Leo Pharma A/S (DK) | 2003-04-23 | — | — | EP | disclosed |
| US-6521606-B2 | 2-(4-Chlorophenoxy)-2-oxo-1,3,2-oxazaphosphorinane-3-aceto -hydroxamic acid, for example; antiathritic, -tumor, -metastasis, -proliferative and -ulcer agents; multiple sclerosis; vision defects; skin disorders | LEO PHARMACEUTICAL PRODUCTS, LTD. A/S (DK) | 2003-02-18 | — | — | US | disclosed |
| US-20020103166-A1 | Matrix metalloproteinase inhibitors | LEO PHARMACEUTICAL PRODUCTS, LTD. A/S (DK) | 2002-08-01 | — | — | US | disclosed |
| WO-2002006293-A1 | MATRIX METALLOPROTEINASE INHIBITORS | LEO PHARMA A/S (DK) | 2002-01-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090043032-A1 | REACTIVE FLAME RETARDANT AND FLAME-RETARDANT RESIN PROCESSED ARTICLE | F11, PF4, RXRA | CYP1A2 1727/4885ALDH1A1 2920/4885ACP3 747/4885 |
| US-20190352318-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | L1CAM, EFNA1, EPCAM | CYP1A2 441/4885ALDH1A1 33/4885ACP3 3512/4885 |
| US-20020103166-A1 | Matrix metalloproteinase inhibitors | MMP1, MMP9, MMP8 | CYP1A2 1649/4885ALDH1A1 411/4885ACP3 2577/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.